Skip to content
    Clinical Trials

    Estriol-Lactobacilli Regimen vs Polycarbophil Moisturizer for Post-Radiation Vaginitis

    Koohachaiskun et alThe Journal of Obstetrics and Gynecology Research

    Estriol-Lactobacilli Regimen vs Polycarbophil Moisturizer for Post-Radiation Vaginitis
    Pelvic radiotherapy for cervical cancer frequently induces persistent vaginal toxicity, mucosal atrophy, and sexual dysfunction. An open-label randomized controlled trial (TCTR2024051001) assessed the therapeutic efficacy of a 4-week regimen comparing an estriol-lactobacilli combination vaginal tablet (E3/L; Gynoflor) to a polycarbophil-based vaginal moisturizer (PBVM; Regelle) in 34 women with Stage I–III cervical cancer experiencing post-radiation vaginitis symptoms.
    The primary outcome of vaginal epithelial maturation showed superior recovery in the active hormonal-probiotic cohort: the median improvement in vaginal maturation value (VMV) was 19.65 points (IQR: 0–39.5) in the E3/L arm versus 2.08 points (IQR: 0–20.1) in the PBVM arm (p = 0.035; 95% CI: 10.22–32.59). In secondary analyses, the E3/L group achieved significant improvements in vaginal dryness and local inflammation. However, no significant between-group differences emerged regarding changes in vaginal pH, dyspareunia, or vaginal pain. While the change in Female Sexual Function Index (FSFI) scores favored the E3/L cohort (median improvement of +6 vs. +2; p = 0.01), absolute FSFI scores at week 4 were comparable between arms, leaving the clinical significance of this functional change uncertain.
    Both interventions were well tolerated with favorable short-term safety profiles. The investigators noted that findings remain exploratory due to the modest sample size (n = 34), open-label design, and brief 4-week follow-up, emphasizing the need for larger, double-blind trials with longer monitoring periods to establish definitive clinical efficacy.

    Key Takeaways

    • Estriol-lactobacilli combination therapy produced a significantly higher median increase in vaginal maturation value compared with polycarbophil-based moisturizer (19.65 vs. 2.08 points; p = 0.035; 95% CI: 10.22–32.59) over 4 weeks.
    • The estriol-lactobacilli regimen demonstrated significant reductions in vaginal dryness and inflammation along with a greater increase in Female Sexual Function Index score (median change +6 vs. +2; p = 0.01), whereas changes in vaginal pH, dyspareunia, and vaginal pain did not significantly differ between cohorts.
    Read the original sourceThe Journal of Obstetrics and Gynecology Research